These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9539361)

  • 1. P-selectin expression in canine cutaneous inflammatory diseases and mast cell tumors.
    Chénier S; Doré M
    Vet Pathol; 1998 Mar; 35(2):85-93. PubMed ID: 9539361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of E- and P-selectin in tumor necrosis factor-induced dermatitis in dogs.
    Tremblay C; Paradis M; Doré M
    Vet Pathol; 2001 May; 38(3):261-8. PubMed ID: 11355655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology of canine cutaneous round cell tumors. Mast cell tumor, histiocytoma, lymphosarcoma and transmissible venereal tumor.
    Duncan JR; Prasse KW
    Vet Pathol; 1979 Nov; 16(6):673-9. PubMed ID: 228464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.
    Fernandez NJ; West KH; Jackson ML; Kidney BA
    Vet Pathol; 2005 Jul; 42(4):437-45. PubMed ID: 16006603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitosis and apoptosis in canine cutaneous histiocytoma and transmissible venereal tumour.
    Guvenc T; Haligur M; Orman MN; Haziroglu R
    Acta Vet Hung; 2002; 50(3):315-21. PubMed ID: 12237973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin expression in canine cutaneous histiocytomas.
    Baines SJ; McInnes EF; McConnell I
    Vet Rec; 2008 Apr; 162(16):509-13. PubMed ID: 18424847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules.
    Moore PF; Schrenzel MD; Affolter VK; Olivry T; Naydan D
    Am J Pathol; 1996 May; 148(5):1699-708. PubMed ID: 8623937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
    Fröberg GK; Lindberg R; Ritter M; Nordlind K
    J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of E-cadherin does not distinguish canine cutaneous histiocytoma from other canine round cell tumors.
    Ramos-Vara JA; Miller MA
    Vet Pathol; 2011 May; 48(3):758-63. PubMed ID: 21285383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of p27 and p21 in canine cutaneous mast cell tumors and histiocytomas.
    Wu H; Hayashi T; Inoue M
    Vet Pathol; 2004 May; 41(3):296-9. PubMed ID: 15133184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of P-selectin expression by inflammatory mediators in canine jugular endothelial cells.
    Doré M; Sirois J
    Vet Pathol; 1996 Nov; 33(6):662-71. PubMed ID: 8952025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staining of mast cell granules by the Ziehl-Neelsen method and differential diagnosis of malignant dermal tumours in the dog.
    Rest JR; Lee RL
    Vet Rec; 1979 Jan; 104(4):79. PubMed ID: 86228
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of major histocompatibility complex class II antigen in neoplastic cells of canine cutaneous histiocytoma.
    Kipar A; Baumgärtner W; Kremmer E; Frese K; Weiss E
    Vet Immunol Immunopathol; 1998 Mar; 62(1):1-13. PubMed ID: 9618864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine mast cell tumors: a comparison of staining techniques.
    Simoes JP; Schoning P
    J Vet Diagn Invest; 1994 Oct; 6(4):458-65. PubMed ID: 7532014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine mast cell tumors express stem cell factor receptor.
    Reguera MJ; Rabanal RM; Puigdemont A; Ferrer L
    Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
    Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
    J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors.
    Ginn PE; Fox LE; Brower JC; Gaskin A; Kurzman ID; Kubilis PS
    Vet Pathol; 2000 Jan; 37(1):33-9. PubMed ID: 10643978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs.
    Patnaik AK; Ehler WJ; MacEwen EG
    Vet Pathol; 1984 Sep; 21(5):469-74. PubMed ID: 6435301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of canine mast cell tumors for presence of estrogen receptors.
    Larsen AE; Grier RL
    Am J Vet Res; 1989 Oct; 50(10):1779-80. PubMed ID: 2508516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.